Companies / BOC Sciences / Minretumomab
BOC Sciences

Minretumomab | BOC Sciences

Minretumomab is a mouse monoclonal antibody directed against TAG-72. Minretumomab has been developed for the treatment of cancer expressing the TAG-72 antigen.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.